<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00938002</url>
  </required_header>
  <id_info>
    <org_study_id>09-0321</org_study_id>
    <secondary_id>UL1RR025780</secondary_id>
    <nct_id>NCT00938002</nct_id>
  </id_info>
  <brief_title>Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill Patients</brief_title>
  <official_title>Rapid Bacterial Identification and Antibiotic Resistance Testing in Critically Ill Adults at Risk for Ventilator Acquired Pneumonia (VAP).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Denver Health and Hospital Authority</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Accerl8 Technology Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Center for Research Resources (NCRR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Denver Health and Hospital Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Critically ill patients on a breathing machine are at risk of developing a type of pneumonia&#xD;
      called Ventilator Acquired Pneumonia (VAP). The purpose of this study is to determine if&#xD;
      regular lung rinses sent for microbiological testing can reduce the time to diagnose VAP. The&#xD;
      study also plans to test the accuracy and speed of a new technology, using multiplexed&#xD;
      automated digital microscopy, to identify the germs causing the VAP.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ventilator-associated pneumonia (VAP) is a common, life-threatening hospital-acquired&#xD;
      infectious complication of prolonged mechanical ventilation (MV). Despite aggressive efforts&#xD;
      to prevent VAP, rates remain high because clinical diagnosis is imprecise and microbiological&#xD;
      diagnosis is frequently delayed. Diagnosis of VAP depends on clinical signs as well as&#xD;
      microbiologic evidence from Bronchioalveolar Lavage (BAL) cultures. Ordinarily, these&#xD;
      cultures are only ordered after the patient presents with clinical signs and symptoms of VAP,&#xD;
      which can significantly delay diagnosis and effective therapy. This research proposes to&#xD;
      implement additional surveillance BAL cultures in order to reduce the time to diagnosis of&#xD;
      VAP in mechanically ventilated critically ill adults. To further reduce the time to diagnosis&#xD;
      of VAP, this research aims to test part of the BAL cultures using a novel&#xD;
      flowcell/surface-capture device that allows direct from specimen visualization of bacteria&#xD;
      using multiplexed automated digital microscopy (BACcel™) for rapid bacterial identification&#xD;
      and antibiotic resistance testing. Additionally, molecular assays of the BAL sample will&#xD;
      characterize lower respiratory tract antimicrobial peptide host-innate immune molecule and&#xD;
      local anti-oxidant defenses in mechanically ventilated adults at risk for VAP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">September 19, 2019</completion_date>
  <primary_completion_date type="Actual">September 19, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in time to diagnosis and treatment of VAP in an at risk population</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <enrollment type="Actual">37</enrollment>
  <condition>Ventilator Acquired Pneumonia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Acceler8 Pheno</intervention_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA collected from whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill ventilated patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Written, informed consent (by surrogate if unconscious or if altered mental status)&#xD;
&#xD;
          2. ≥ 18 years old&#xD;
&#xD;
          3. Admission to a Medical Intensive care unit&#xD;
&#xD;
          4. Orally/nasally intubated, evaluable within 72 h of initial intubation&#xD;
&#xD;
          5. Expected to remain mechanically ventilated for at least 48 h after the first study&#xD;
             procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previously documented cystic fibrosis&#xD;
&#xD;
          2. Diffuse bronchiectasis&#xD;
&#xD;
          3. Severe or massive hemoptysis&#xD;
&#xD;
          4. Presence of an advanced directive to withhold life-sustaining treatment&#xD;
&#xD;
          5. Morbid state or expected to survive less than 14 days because of an advanced co-morbid&#xD;
             medical condition&#xD;
&#xD;
          6. Participation in a clinical trial of any unlicensed drug or device within 30 days&#xD;
&#xD;
          7. Pregnant or Nursing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ivor S Douglas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Denver Health and Hospital Authority</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Connie S Price, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Denver Health and Hospital Authority</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Denver Health Medical Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>July 10, 2009</study_first_submitted>
  <study_first_submitted_qc>July 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2009</study_first_posted>
  <last_update_submitted>December 22, 2019</last_update_submitted>
  <last_update_submitted_qc>December 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Denver Health and Hospital Authority</investigator_affiliation>
    <investigator_full_name>Ivor Douglas</investigator_full_name>
    <investigator_title>Chief, Pulmonary Sciences &amp; Critical Care Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

